This list is an analysis based on recent market events. It's not an investment recommendation.
Renovacor is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor’s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
Show more...
FAQ
What is Renovacor stock price today?▼
The current price of RCOR is $3.20 USD — it has increased by +4.92% in the past 24 hours. Watch Renovacor stock price performance more closely on the chart.
What is Renovacor stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Renovacor stocks are traded under the ticker RCOR.
What is Renovacor market cap?▼
Today Renovacor has the market capitalization of 55.26M
How many employees does Renovacor have?▼
As of July 16, 2026, the company has 2 employees.
In which sector is Renovacor located?▼
Renovacor operates in the Technology sector.
When did Renovacor complete a stock split?▼
Renovacor has not had any recent stock splits.